Rare disease biomarker discovery at Nexomic Limited applies AI-powered multi-omics approaches to uncover novel biomarkers for rare and understudied conditions, facilitating better diagnosis, treatment development, and translational research.
Nexomic Limited hasn't taken the fitness assessment yet.
About
Rare disease biomarker discovery at Nexomic Limited applies AI-powered multi-omics approaches to uncover novel biomarkers for rare and understudied conditions, facilitating better diagnosis, treatment development, and translational research.